Tuesday, December 29, 2009
The four-speaker panel, which brings diverse expertise to the discussion, is moderated by Dennis Tribble, PharmD, Chief Pharmacy Officer for Baxa Corporation. Program speakers are Rita Shane, PharmD, FASHP - Director of Pharmacy Services at Cedars-Sinai Medical Center; Seth Eisenberg, RN, ASN, ONC®, the Professional Practice Coordinator of Infusion Services at Seattle Cancer Center; Patricia Kienle, RPh, MPA, FASHP - Director of Clinical Accreditation and Medication Safety, Quality and Regulatory Affairs for Cardinal Health Pharmacy Solutions; and John Poikonen, PharmD - the Director of Clinical Informatics at UMass Memorial Medical Center.
Link to the PR Web newswire
Monday, December 28, 2009
Link to yearend review on PR Web
Saturday, December 26, 2009
"As put in the words of Marian Robinson, Vice President of Marketing for Baxa, 'DoseEdge does not compete with RIVA. What makes IntelliFill I.V. compelling is that it was the first to market automated solution for IV dose filling. It is the only system with a proven track record – with more than 30 customers in the US and nearly 30 million prepared doses to date. In addition, the IntelliFill i.v. features high-speed dose automation – preparing 300 doses per hour in reservoir mode.'"
Link to Ruben Dagda's report
Monday, December 21, 2009
Link to the overview
Monday, December 14, 2009
Thursday, December 10, 2009
Link to Dr. Lucas' column about teaching cosmetic acupuncture in Turkey
Colorado BioScience Association Moves Offices with Two Other Associations to Columbine Place at 216 16th Street, Suite 850, Denver
Link to the Genetic Engineering & Biotechnology News posting
Monday, December 07, 2009
The Denver-based medical device company has survived three economic downturns since it launched in the recession of 1982, emerging with a different business model each time."
Pictured is Thomas Geimer, chairman and CEO of Accelr8 Technology Corp. Jacinta Schraufnagel is working in the lab (Business Journal photo by Kathleen Lavine).
The CBSA President & CEO John Collar had this to say in the article about the challenge of finding new funding:
"It’s a classic predicament in the medical device industry, which is filled with small companies creating technology on unpredictable budgets, said John Collar, CEO and president of Colorado BioScience Association trade group.
It’s what he calls the 'high pucker factor' of the business.
'You’re spending money you don’t have, and you probably don’t know where more will come from when you need it,' he said."
Link to the Denver Business Journal article
Baxa is showcasing its new DoseEdge Workflow Manager at the largest gathering of pharmacists in world
Introduced at the 2007 MCM, DoseEdge – formerly IntelliFlowRx™ – has processed more than 1,000,000 pharmacy doses to date. Today, 1,400 health-system users are managing dose preparation and barcode tracking through the system, which has resulted in the detection and rejection of approximately 30,000 product scan errors to date.
Link to the PRWeb Newswire
Friday, December 04, 2009
The reps spent a day touring the Vestas wind turbine blade manufacturing plant in Windsor, the National Renewable Energy Laboratory in Golden, and the wind energy research lab in Boulder that’s operated by German company Siemans Energy Inc.
The German-American Chamber of Commerce’s Colorado chapter sponsored the group, whose members also spoke at a Nov. 13 networking breakfast. The Colorado Cleantech Industry Association and the Colorado Office of Economic Development and International Trade sponsored the breakfast."
Link to the DBJ article: German energy companies tour Colorado
Thursday, December 03, 2009
“Colorado's solar manufacturers have noted that they benefit from the state's low business costs, availability existing facilities for ramp up of production, and a local workforce familiar with technologies applicable to solar manufacturing,” says Christine Shapard, executive director, Colorado Cleantech Industry Association.
Link to article posting
Monday, November 30, 2009
Denver's Baxa Corp to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned
The recent conviction of health-system pharmacist Eric Cropp for a medication error heightened awareness of the cultural and operational issues around safe practice. The Baxa program features a four-speaker panel with diverse expertise, permitting discussion of the controversy around medication errors, error reporting and promoting safety through cultural changes in health-system pharmacy. Moderated by Dennis Tribble, PharmD, Baxa Corporation Chief Pharmacy Office; the program speakers are Rita Shane, PharmD, FASHP – Director of Pharmacy Services at Cedars-Sinai Medical Center; Seth Eisenberg, RN, ASN, ONC®, the Professional Practice Coordinator of Infusion Services at Seattle Cancer Center; Patricia Kienle, RPh, MPA, FASHP – Director of Clinical Accreditation and Medication Safety, Quality and Regulatory Affairs for Cardinal Health Pharmacy Solutions and John Poikonen, PharmD – the Director of Clinical Informatics at UMass Memorial Medical Center.
Link to the PR Web newswire
Link to Register
Tuesday, November 24, 2009
The large suite allows for each association to have their own office areas, a large conference room to hold meeting space, and an open area for association members to come and work while in the Denver area.
Link to the Business Wire release
Tuesday, November 17, 2009
BioWest 2009 Video Recap - Who Stood Out In The Crowd and The Rocky Mountain Life Science Investor Conference
Leap Frogg Investor Presentation Matthew J Mayer, CEO Part 1 (three parts)
BioAMPS Investor Presentation David DeLong, CEO Part 1 (three parts)
Investor Presentation BioWest 2009 Panel Discussion Part 1 (two parts)
Go to CBSA's main YouTube channel page
Monday, November 16, 2009
Thank you to our friend Bertil Nordquist and the team at the European Life Science Journal!
Link to the PRWeb newswire
Sunday, November 08, 2009
The companies manufacture equipment for the wind energy industry, from the bolts that hold the turbine together to the hand tools used by maintenance workers on wind farms.
. The Colorado Cleantech Industry Association will host a breakfast for the delegation, where members will make presentations about their companies, Friday morning, Nov. 13, at the Denver Metro Chamber of Commerce. The Colorado Office of Economic Development and International Trade helped to put together the breakfast, Cheatham said.
For information about registering for the Cleantech association's breakfast, call the association at 303-623-2690.
Link to the DBJ posting
Friday, November 06, 2009
Link to the Denver Post Colorado Business section
Link to the 2009 BioWest site
Thursday, November 05, 2009
Official presentation of the awards occurs Tuesday, November 10, 6:00 to 8:30 p.m., at the Denver Grand-Hyatt, 1750 Welton. Held in conjunction with the 2009 BioWest Conference & Expo, registration information is available at http://www.biowestconference.com/. BioWest is the region’s preferred venue for meeting investors, entrepreneurs, researchers, students, teachers and key industry vendors.
Eric Alexander, skier, rock climber and mountaineer will serve as the keynote speaker for the event as the Colorado Bioscience Association celebrates its sixth anniversary. In addition, Steffan Tubbs, host of 850 KOA’s Colorado’s Morning News and KBDI-TV’s “Studio 12,” will act as the Master of Ceremonies for the award presentations.
Recipients of the CBSA’s 2009 awards include:
* Partner of the Year – Colorado Office of Economic Development and International Trade (OEDIT) - The CBSA, as well as Colorado’s bioscience companies, rely on numerous, highly-respected partners to be successful. Since the inception of the CBSA, the Colorado Office of Economic Development has been an outstanding partner and friend to the bioscience industry in the state. The OEDIT has been engaged with CBSA on a number of levels, from helping ensure that Colorado’s bioscience industry remains a top priority for the state to the creation of the Bioscience Discovery Evaluation Grant Program. The great success this state’s bioscience industry has seen over the years is due in great part to the dedication and hard work of everyone at the Office of Economic Development and International Trade. For more information: http://www.colorado.gov/cs/Satellite/OEDIT/OEDIT/1162927366334
* Lifetime Achievement – Thomas Cech, PhD – Dr. Thomas Cech, Nobel Laureate, Distinguished Professor for the University of Colorado, Director of the new Colorado Initiative in Molecular Biotechnology (CIMB) and Investigator for the Howard Hughes Medical Institute has become a leader in the bioscience industry and has encouraged others to follow his path. Dr. Cech first joined the faculty of the University of Colorado, Boulder in 1978 where he became a Howard Hughes Medical Institute Investigator in 1988 and a Distinguished Professor of Chemistry and Biochemistry in 1990. In 1982 Dr. Cech and his research group discovered that RNA was not restricted to being a passive carrier of genetic information, but could have an active role in cellular metabolism. This discovery of self-splicing RNA provided the first exception to the long-held belief that biological reactions are always catalyzed by proteins. This year Dr. Cech returned to Colorado full-time as the University of Colorado as the Director of the Colorado Initiative in Molecular Biotechnology, coming from his post as the President of the Howard Hughes Medical Institute since 2000. For more information: http://cimb.colorado.edu/
* Lifetime Achievement – Leslie Leinwand, PhD – Dr. Leslie Leinwand, Interim Director of the Linda Crnic Institute for Down Syndrome, Chief Science Officer of the new Colorado Initiative in Molecular Biotechnology, and Professor at the University of Colorado at Boulder is a true leader in the bioscience industry. Since 2003, Dr. Leinwand has lead the initiative to begin the CIMB in order to foster new research, teaching and technology development in the fields of life sciences, physical sciences, math, computational sciences and engineering which is on the cutting edge of bioscience education. She is also a co-founder of Myogen Inc., a highly successful CU spin-out that was acquired by Gilead for $2.5 billion. Following the acquisition of Myogen, she began Hiberna Corporation which is studying the Burmese python in order to develop treatments to combat cardiac hypertrophy. For more information: http://cimb.colorado.edu/
* Company of the Year – Accera, Inc. - During the past 12 months Accera has made several notable achievements at the state and national level. In March the company achieved the goal that all start-up companies are strivinv for, they successfully launched Axona, a new prescription therapeutic product for Alzheimer’s disease (AD), nationally in the US. This is the first new evidence-based therapeutic for AD in 10 years, and the first to demonstrate a powerful pharmacogenomic-based efficacy. Accera built its own commercial development capability by utilizing many Colorado-based companies for marketing, sales, manufacturing, etc. and hired new commercial employees from the local biotech market thereby putting their dollars to work in order to further grow the Colorado biotech industry. Today, Accera is the only Colorado-based company with a therapeutic product on the market. Accera is the first and only private biotech company in the US to have researched, developed and launched a prescription CNS product, and to have done it in record time – 8 years from inception to launch. For more information: http://www.accerapharma.com/
* Rising Star – miRagen Therapeutics - miRagen Therapeutics was founded in 2007 to improve patients’ lives by developing innovative microRNA based therapeutics for the treatment of cardiovascular and muscle disease. As of June 2009, miRagen has achieved several key milestones resulting in the approval of the second tranche of their 2008 Series A financing of $8 million. In addition, miRagen secured a $4 million extension of the Series A, bringing the total funding of the Series A financing to $12 million. The company also engaged three new investors Amgen Ventures, Broadview Ventures and The Peierls Foundation who join founding investors Atlas Venture and Boulder Ventures. For more information: http://www.miragentherapeutics.com/
* Volunteer of the Year – Dan Mitchell – Dan Mitchell, Partner at Sequel Ventures, sits on the board of the CBSA and is an active member of the board. His commitment to the organization is evident when we take a look back on this year’s first Rocky Mountain Life Science Investor Conference, which would not have been possible without Dan’s hard work, dedication and support. Dan was instrumental in engaging outside investors to attend the conference, and securing sponsorships for the Investor Conference. Along with the Investor Conference, Dan has been an active participant in many of CBSA’s programs and has truly given his all to see the success of this organization. For more information visit: http://www.sequelvc.com/index.php?page=partners_sub&p=4
* Educator of the Year – Dr. Corinne Carlson – Dr. Corinne Carlson is a biology and chemistry teacher at Rock Canyon High School in Douglas County. Dr. Carlson is a PhD in biochemistry and comes back to teach high school after working as a researcher and professor at the University of Colorado. Dr. Carlson returned back to teaching high school students due to her passion and desire to inspire young people into the biosciences and chemical science orientated careers.
* Educator of the Year – Dr. Todd Bergren is the Chair of the State Faculty Advisory Council (SFAC) for the community college system of Colorado and also is a full time biology professor at the Community College of Aurora (CCA) where he has taught for the last 15 years. Dr. Bergren is known by both students and teachers alike as a truly passionate and inspirational teacher. Dr. Bergren has impacted numerous students to achieve their goals and to pursue the impossible, and through his research and teachings he has inspired many students to understand and love science.
* Chairman’s Award – Erin Silver, MPH- Erin Silver has been the contract lobbyist for the CBSA since 2005. Through Erin’s commitment to the organization and to our companies, the CBSA has successfully passed each legislative initiative that they have put forth to the state’s General Assembly. The legislation has provided $26.5 million for proof-of-concept and early stage companies, tax incentives and credits which encourage bioscience companies to move to the state and remain here, and they have helped create infrastructure to support the bioscience community. Her awareness of our industry’s needs and her brilliant ability to advocate on its behalf has made the CBSA the preeminent industry organization in Colorado. For more information: http://rbwpolicy.com/principals.php?pid=2
Thursday, October 29, 2009
Expo at BioWest 2009 Showcases New Technology, Products and Services for the Region’s Robust Bioscience Industry
More than 40 exhibitors will be showcasing new technology, products and services for 700+ attendees at the 2009 BioWest Conference and Expo. The announcement is made by John Collar, President and CEO of the Colorado BioScience Association (CBSA), who says the event is November 10 at the Grand Hyatt Denver, 1750 Welton.
“The companies participating in the exhibit area are each playing an important role in helping advance the bioscience industry within the region,” Collar said, “We’re very pleased to welcome them to our seventh annual BioWest event and are looking forward to yet another exciting and successful conference.”
BioWest is the Rocky Mountain region’s preferred venue for visiting and learning about the bioscience industry. Exhibitors confirmed to date include:
Biologics Consulting Group, Inc., http://www.biologicsconsulting.com
Canadian Consulate, http://www.canadainternational.gc.ca/denver/index.aspx
CARE Research, Inc., http://www.care-research.net
CGL - Concert Group Logistics, http://www.cglship.com
Colorado Science + Technology Park at Fitzsimons, http://www.fitzscience.com
Compliant Logistics, http://www.compliantlogistics.com
Concrete Floor Systems, http://www.concretefloorsystems.com
Colorado Prevention Center, http://www.cpcmed.org
CRB Engineers & Builders, http://www.crbusa.com
Colorado State University Research Foundation, http://www.csurf.org/researcher.html
Diablo Sales and Marketing, http://www.diablosales.com
Evergreen Research, Inc., http://www.evergreenresearch.com
Extronex Inc., http://www.extronex.com
GEL Analytics, LLC, http://www.gel.com
HemoGenix, Inc., http://www.hemogenix.com
Howe Creative, http://www.howecreative.com
ISEC, Inc., http://www.isecinc.com
Jefferson Economic Council, http://www.jeffco.org
Keystone Symposia on Molecular and Cellular Biology, http://www.keystonesymposia.org
LABS Inc., http://www.labs-inc.org
Leeds Precision Instruments, http://www.leedsmicro.com
Leo A Daly, http://www.leoadaly.com
Quest Product Development, http://www.quest-corp.com
Reglera, LLC, http://www.reglera.com
Sheridan Ross P.C., http://www.sheridanross.com
TDC Medical, Inc., http://www.tdcmedical.com
Technology Driven Products, http://www.tdpcorp.com
The Jackson Laboratory, http://www.jax.org
The Neenan Company, http://www.neenan.com
Ubiquity Group, http://www.ubiquity-design.com
University of Colorado Tech Transfer Office, http://www.cu.edu/techtransfer
We Work for Health, http://www.weworkforhealth.org
YSI, Inc., http://www.ysilifesciences.com
There is still exhibit space available for the Expo on a first-come, first-served basis. Contact Leah Kientz at 303-592-4088 if you are interested in being part of the 2009 Expo. Conference registration is required in order to view the Exhibitor Hall area. Complete registration details for the BioWest Conference and Expo are available at http://www.biowestconference.com.
Link to the video of the keynote by Dave Markham, Lockheed Martin, at the CCIA's Smart Grid session 2: Technical Challenges Ahead held yesterday (10/28/09) at the Denver Chamber.
Additional panel participants included: Dr. Frank Barnes, CU/Boulder; David Cohen, Infotility; and Marcia Martin, Magpie.
Dave Markham's remarks are available in three parts at the CCIA YouTube channel.
Sunday, October 25, 2009
Friday, October 23, 2009
The relocation will consolidate Baxa’s executive and administrative operations, which are now in three separate locations. Baxa expects to move into its new space in May 2010.
According to Dustin Whistler of Forte Commercial Real Estate, "This transaction represents one of the top real estate deals in the metro area this year. At the time of signature, this was the largest new lease signed in the submarket in 2009." Forte provided brokerage and transaction management services for this and previous Baxa Corporation real estate projects and assisted the company with site selection and assembly of the tenant’s external team of professionals.
Wednesday, October 21, 2009
Organizers expect more than 700 industry leaders November 10th for the seventh annual BioWest event, held again at the Grand Hyatt Denver, 1750 Welton.
Tuesday, October 20, 2009
The move into the China market comes after China's State Council recently allocated $123 billion for medical and health-care improvements, including medical technology, Baxa said."
Monday, October 19, 2009
The partners anticipate that Baxa Corporation’s expertise in automation could greatly improve the existing processes in Chinese hospitals – making their pharmacy operations more accurate, safe and efficient. “Baxa products are used all across the world every day by thousands of pharmacies. By entering the Chinese market, patients there will access the same outstanding quality that Baxa products have provided for 35 years in other parts of the world,” states Phil Walsh, Baxa Director of International Sales.
Wednesday, October 14, 2009
Tuesday, October 13, 2009
The annual Women of Distinction program is widely regarded as the one of Denver’s premier philanthropic programs, bringing together and recognizing a group of purpose-driven leaders, women in business, government and philanthropic communities; who, like the girls, are dedicated to service and leadership. My good friend Rae Ann Dougherty was one of the honorees this year.
Link to more information about the program
"Biology teacher Tammy Hearty enjoyed going 'back to school' this past summer.
Better yet, she’s happy she didn’t blow up anything during her stint in the laboratory at OSI Pharmaceuticals in Boulder.
Hearty, who teaches honors biology at Fairview High School in Boulder, was part of a Colorado BioScience Association (CBSA) program that connects teachers with local businesses to help them learn about their subject matter from the inside."
John Collar, CEO and president of the Colorado BioScience Association (CBSA) trade group, flew to Washington, D.C., at the end of September to tell Sens. Mark Udall and Michael Bennet that the industry sees the fees proposed in Sen. Max Baucus’ leading bill as a potential disaster.
Friday, October 09, 2009
Denver-based Cosmetic Acupuncture Expert Dr. Martha Lucas Conducts Intensive Seminar Sessions for Physicians in Istanbul
Wednesday, October 07, 2009
Tuesday, October 06, 2009
The CCIA held the first of three sessions on Smart Grid, September 30, 2009. Video recaps are now available of the first session at the CCIA's YouTube Channel: http://www.youtube.com/COCleantech
Link to the CCIA YouTube Channel
Wednesday, September 30, 2009
Baxa Addresses Health-System Capital Shortage with New Programs for IntelliFlowRx™ and IntelliFill i.v.®
“Our goal was to make it easy for health systems to improve their pharmacy operations,” notes Greg Baldwin, Baxa CEO. “We feel that patient safety improvements shouldn’t take a back seat to this economy’s capital crunch. The IntelliSource pricing model makes it easy for health systems to install the latest pharmacy technology, eliminating the need for capital investment and providing manageable monthly fees for access.”
Thursday, September 24, 2009
Denver-based Cosmetic Acupuncture Expert Dr. Martha Lucas Conducts Intensive Seminar Sessions for Physicians in Istanbul
A physician from Antalya, Turkey, had attended one of Dr. Lucas' cosmetic acupuncture seminars in the States last year and asked if she would teach Mei Zen™ Cosmetic Acupuncture in Turkey this year. According to Dr. Lucas, it is apparent women all over the world are searching for safe, natural, non-invasive cosmetic procedures of which Cosmetic Acupuncture is becoming one of the most popular.
Wednesday, September 23, 2009
The Colorado Cleantech Industry Association Announces Its Three-part "Smart Grid, Technology and Colorado" Series
The Series Kicks Off with Keynote Speaker Luke Clemente of General Electric (http://ge.ecomagination.com/smartgrid).
Registration is required, contact Shelly Curtiss at 303-623-2690 or Shelly@coloradocleantech.com – CCIA members attend free of charge; $50 for non-members. Subsequent sessions in the series are scheduled for Wednesday, October 28, and Tuesday, November 10. A breakfast buffet is provided at each of the sessions. Note space is limited and reservations are on a first-come, first-served basis. For more information, visit http://www.coloradocleantech.com/events.html
Tuesday, September 22, 2009
True, a lot of good new medicines are coming out of each of the above regions, but good medicine, diagnostics and medical devices is not the purview of these regions only. Last week, while visiting Denver I participated in two different meetings which showed me that biotech is alive, abundant and well in Colorado and the Rocky Mountain region.
Sunday, September 20, 2009
Dr. Tom Cech's Rocky Mountain Life Science Investor Conference Keynote available at the COBioscience YouTube Channel
Over the last year, the State of Colorado has been anticipating Dr. Tom Cech's return to the University of Colorado Boulder and the implementation of the new Colorado Initiative for Molecular Biotechnology (CIMB). Dr. Cech provided the luncheon keynote presentation during the Rocky Mountain Life Science Investor Conference (Denver, Sept 17, 2009) and gave the audience a preview into his research and what the future holds. The CIMB will be opening its doors in December of 2011, and during Dr. Cech's presentation he discusses the collaboration and innovation that will generate from this unique project.
This is the first of four parts covering Dr. Cech's keynote at the Rocky Mountain Life Science Investor Conference Sept. 17, 2009, Ritz-Carlton, Denver.
Link to the COBioscience YouTube Video Channel
Friday, September 18, 2009
Wednesday, September 16, 2009
'We are excited to welcome over 30 of the life science community’s most renowned investors to the inaugural Rocky Mountain Life Science Investor Conference,' said John Collar, President and CEO of the Colorado BioScience Association. 'This will allow Colorado and the Rocky Mountain region to offer an inside look into the innovation and talent that lies in this region, and we can’t wait to see the partnerships and connections made during this conference.'"
Rocky Mountain Life Science Investor Conference: two Tucson bioscience firms picked to present to investors
The two Tucson firms are High Throughput Genomics and Medipacs. . .
Friday, September 11, 2009
The Rocky Mountain Investor Conference
The 2009 Summer Externship Program
Letter from John Collar, CBSA President & CEO
The Fitz Bulletin Board: 2009 BioSymposium on Pulmonary Disease
Joe Kernen discussing the future of biomedical research, with Thomas Cech, 1989 Nobel Laureate in chemistry.
View the video at Medical Miracles - CNBC.com
Read "the rest of the story" about Joe Kernen at the Colorado Life Science Deal Flow blog
Make plans to attend the Sept 17 Rocky Mountain Life Science Investor Conference (RMLIC), where you'll get to hear Dr. Cech in person -- http://www.rmlic.com
Link to the latest RMLIC news release posted on the CNBC website
Thursday, September 10, 2009
“We are excited to welcome over 30 of the life science community’s most renowned investors to the inaugural Rocky Mountain Life Science Investor Conference,” said John Collar, President and CEO of the Colorado BioScience Association. “This will allow Colorado and the Rocky Mountain region to offer an inside look into the innovation and talent that lies in this region, and we can’t wait to see the partnerships and connections made during this conference.”The 31 Investor firms and companies attending to date for the September 17 Conference include:
o Celgene, http://www.celgene.com
o Chart Life Scienceso Clovis Oncology
o Covidien, http://www.covidien.com
o Frazier Healthcare Ventures, http://www.frazierhealthcare.com
o Genentech, http://www.gene.com
o H.I.G. Ventures, http://www.higventures.com
o High Country Ventures, http://www.coloradofund1.com
o Hunt BioVentures, http://www.huntbioventures.com
o Johnson & Johnson, http://www.jjdevcorp.com
o Keld, LLC, http://www.keldllc.com
o KRG Capital Partners, http://www.krgcapital.com
o Lilly Ventures, http://www.lillyventures.com
o Mesa Verde Venture Partners, http://www.mesaverdevp.com
o Morgenthaler Ventures, http://www.morgenthaler.com
o NovaQuesto Novartis Venture Fund, http://www.venturefund.novartis.com
o Prairiegold Ventures, http://www.pgvp.com
o Puente Partnerso Red Script, http://www.jjdevcorp.com
o Rocky Mountain Venture Capital Association, http://www.rockymountainvca.com
o Sequel Ventures, http://www.sequelvc.com
o Skyline Ventures, http://www.skylineventures.com
o Sun Mountain Capital, http://www.sunmountaincapital.com
o Technology Partners, http://www.technologypartners.com
o Telegraph Hill Partners, http://www.thpartners.net
o vSpring Capital, http://www.vspring.com
o Yasuda Enterprise Development, http://www.yedvc.co.jp
Wednesday, September 09, 2009
Monday, September 07, 2009
Sunday, September 06, 2009
University of Colorado to break ground on new biotech building that will house the Colorado Initiative in Molecular Biotechnology
'This building will solidify the University of Colorado's position as a world leader in biotechnology and biochemistry,' said CU President Bruce D. Benson. 'It will provide leading-edge facilities to help foster collaboration among our faculty researchers and students from Boulder, Denver and the Anschutz Medical Campus. It will draw on the talents of scientists and engineers from several disciplines and create an incubator where innovation and discovery thrive.'
For the first time since its formation, the Colorado Initiative in Molecular Biotechnology's research team, a "dream team" of scientists and engineers spanning eight CU departments, will be housed in one location. The team received a boost this year when Cech, 1989 winner of the Nobel Prize in chemistry, rejoined CU's faculty in spring 2009 to head up the initiative."
Saturday, September 05, 2009
"Ovarian Cancer, Awareness Now!" - 2nd Annual Ovarian Cancer March to the Colorado Capitol - Friday, Sept 4, 2009 Arrival at the Capitol Steps
"This is the second year my husband and I participated in support of our dear friend Elaine Rueb -- we also choose to support the COCA effort financially," Maggie Holben says. "The march, however, is about awareness. It was an awesome event again this year."
Friday, September 04, 2009
The information comes from the June 2009 Pew report entitled "The Clean Energy Economy: Repowering Jobs, Businesses and Investments Across the Country." Colorado is singled among the "large and fast growing" category. Quoting from the report: